ImmuSAFE™ COVID+ Biochip

Product Specifications

ImmuSAFE COVID19 Test Biochip Kit | Sengenics Proteomics | Krex Protein Microarrays
Product Namexx
Product NameSengenics Immunome AxCESS Array
PlatformSengenics' proprietary Streptavidin-coated hydrogel surface chemistry provides an aqueous environment, preserving native protein folding and function. Due to the binding of the biotinylated BCCP folding marker with Streptavidin, proteins are oriented consistently with a single attachment point and are also distal (50Å) to the surface further enhancing their capability to fully interact with target biomolecules. KREX proteins behave as if they are in free solution, with full capability to interact at high specificity with autoantibodies and antibodies
Number of arrays2 arrays (2 samples) per slide
Services Services include running of samples on the array using the Sengenics Immunome Protein Array Standard Autoantibody Assay Wet Lab Protocol. Includes quality control and standard fold change analysis using the Sengenics Standard Bioinformatics Pipeline
Sample type

Human serum/plasma
*please contact us for requirements of other types of samples

Delivery Lead Time

(40010) 2 weeks
(40020) 4 weeks

System CompatibilityAny open-format microarray scanner
Storage conditionsStore for up to 12 months at -20°c

Frozen shipment in dry ice

Biochip Layout


Control Probes:

  • Positive control
    1. Cy3-BSA
    2. Cy5-BSA
    3. IgA (positive control for total immunoglobulins detection)
    4. IgG (positive control for IgG and total immunoglobulins detection)
    5. IgM (positive control for IgM and total immunoglobulins detection)
  • Negative control
    1. IgA (negative control for IgG and IgM detection)
    2. IgG (negative control for IgM detection)
    3. IgM (negative control for IgG detection)
    4. Negative control probe for total immunoglobulins detection


IMMUNOME Protein Array

High-throughput multiplexed autoantibody screening protein array containing 1600+


Contains correctly folded antigens from SARS-CoV-2 and 25 other Corona and Influenza

SARS-CoV-2 Antigens

7 Recombinant SARS-CoV-2 antigens expressed using the patented KREX™ functional proteomics technology


Resources to access our technology


Your technical questions - answered


One technology - endless possibilities

Sengenics - Functional Proteomics | Krex Technology | Protein Microarray Supplier

Sengenics is a Functional Proteomics company that leverages its patented KREX technology to discover autoantibody biomarker signatures for prediction of drug response and severe immune-related adverse events (irAEs). KREX can also be used to identify autoantibody biomarkers to diagnose cancer, autoimmune, neurodegenerative or infectious diseases with higher sensitivity and specificity than conventional diagnostic tests. Some autoantibodies that are identified as diagnostic biomarkers may be protective and have potential in themselves as therapeutic biomolecules.

Copyright 2008 – 2021 Sengenics All rights reserved | Sengenics Corporation LLC. Registered in Delaware, USA no. 5739583 | Sengenics UK Registered in England and Wales no. 12889389